GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N95022F00001A&G PHARMACEUTICAL, INC.

Overview

Award facts

Net obligations
$83.4K
$83,401of $105.98K potential value
Outlays (paid to date)
$83.4K
$83.4K paid of $83.4K obligated$83,401
Period of performance
Jun 30, 2022 to Mar 31, 2025
Ended
Modifications
4
Latest action May 5, 2026
Contract type
Delivery order
PIID 75N95022F00001

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

POLYCLONAL RAT ANTIBODY AND MONOCLONAL RAT ANTIBODIES AGAINST GLYCOL-CHITOSAN NANOPARTICLES

Dates and value

Award date
Signed on Jun 30, 2022
Current value
$83,401Base and exercised options
Potential value (if all options are exercised)
$105,983
Parent contract vehicle
75N95018D00010 (IDC, single award) — 7 orders recorded under it

Obligations by fiscal year of action

  • FY2026: -$1,479 (de-obligation)
  • FY2024: $36,900
  • FY2022: $47,980

Total across 3 fiscal years: $83,401

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 5, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationCOLUMBIA, MD
UEISN6SWFABJXL1
CAGE code1T9L5
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)Manufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded from
National center for advancing translational sciences (0875)Program activities075-0875Federal accounts (agency financial reports)

Place of performance

Place of performance
Rockville, Montgomery County, Maryland 20850-2452
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Basic researchBR
Set-aside
Not reported
Contract pricing
Firm fixed priceJ

Contract details

Subcontracting plan
Plan not requiredB
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 30, 2022Base obligation at award: $47,980
Latest action
May 5, 2026 — Funding onlyModification P00004; obligation change -$1,479; funding only: changes obligations, not scope
Latest substantive action
Mar 27, 2024 — Supplemental agreement (within scope)Modification P00002
Latest funding action
May 5, 2026 — Funding onlyModification P00004; obligation change -$1,479; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Funding only2
  • Supplemental agreement (within scope)1
  • Other administrative action1
5 actions recorded, Jun 30, 2022 to May 5, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$1,479
Latest action: change in base and all options
-$1,479

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N950
Transactions recorded under this award key
5

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N950
Treasury accounts
  • 075-2022/2022-0875-000
  • 075-2024/2024-0875-000
Object classes
  • 25.1: Advisory and assistance services
  • 26.0: Supplies and materials
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression